Drug Trial Radar · NCT06651567
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
320
Planned (sponsor's estimate)
Start
Oct 22, 2024
Primary completion
Dec 28, 2027
Study completion Dec 28, 2027
Sponsor
- Lead sponsor
- Intra-Cellular Therapies, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled, flexible-dose study of the efficacy, safety, and tolerability of ITI-1284 in patients with agitation associated with Alzheimer's dementia.
Conditions
- Agitation Associated With Alzheimer's Dementia
Interventions
ITI-1284Drug
ITI-1284 10 mg or 20 mg rapidly disintegrating tablet, taken once daily, sublingual administration
PlaceboDrug
Placebo rapidly disintegrating tablet, taken once daily, sublingual administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohen-Mansfield Agitation Inventory (CMAI) total scoreTime frame: Week 12
Locations
71 sites in 8 countries. Site status is shown where the registry gives one.
Advanced Research Center, Inc
Anaheim, California · Recruiting
ATP Clinical Research
Costa Mesa, California · Completed
National Institute Of Clinical Research
Garden Grove, California · Completed
Wr Pri Llc
Newport Beach, California · Completed
Sunwise Clinical Research
Walnut Creek, California · Recruiting
SFM Clinical Research LLC
Boca Raton, Florida · Recruiting
Envision Trials LLC
Bonita Springs, Florida · Recruiting
Clinical Research of Brandon
Brandon, Florida · Recruiting
Brain Matters Research
Delray Beach, Florida · Completed
Science Connections LLC
Doral, Florida · Recruiting
Direct Helpers Medical Center, Inc.
Hialeah, Florida · Recruiting
Homestead Associates in Research Inc
Homestead, Florida · Recruiting
K2 Medical Research
Maitland, Florida · Recruiting
Neurology Associates PA
Maitland, Florida · Recruiting
Vital Care Research
Miami, Florida · Recruiting
Advance Medical Research Center
Miami, Florida · Suspended
Advanced Clinical Research Network
Miami, Florida · Recruiting
Wellness Research Center
Miami, Florida · Recruiting
Allied Biomedical Research Institute (ABRI), Inc
Miami, Florida · Recruiting
South Florida Research Phase I-IV
Miami, Florida · Recruiting
Miami Jewish Health System
Miami, Florida · Completed
Sunshine Medical Research Studies Inc
Miami, Florida · Recruiting
Charter Research
Orlando, Florida · Recruiting
Combined Research Orlando
Orlando, Florida · Completed
Psych Me Medical Research Inc
Tampa, Florida · Recruiting
Quantum Research Associates Corp
Tampa, Florida · Recruiting
Premiere Research Institute at Palm Beach Neurology
West Palm Beach, Florida · Recruiting
Tufts University School of Medicine
Boston, Massachusetts · Recruiting
Oasis Clinical Research LLC
Las Vegas, Nevada · Recruiting
Bio Behavioral Health
Toms River, New Jersey · Recruiting
Eximia Clinical Research NC
Raleigh, North Carolina · Completed
UT Health San Antonio
San Antonio, Texas · Recruiting
State Psychiatric Hospital - Lovech
Lovech, Bulgaria · Recruiting
Medical Center Medconsult-Pleven
Pleven, Bulgaria · Recruiting
Mental Health Centre Prof. N Shipkovenski EOOD
Sofia, Bulgaria · Recruiting
DCC 'Sv. Vrach and Sv. Sv. Kuzma and Damyan', OOD
Sofia, Bulgaria · Recruiting
Medical Center Hera EOOD
Sofia, Bulgaria · Recruiting
Medical Center Intermedica, OOD
Sofia, Bulgaria · Recruiting
UMHAT Prof. Dr. St. Kirkovich AD
Stara Zagora, Bulgaria · Recruiting
University Hospital Centre Zagreb 1
Zagreb, Croatia · Completed
Showing 40 of 71 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.